Invention Grant
- Patent Title: Artificial intelligence engine architecture for generating candidate drugs
-
Application No.: US17339422Application Date: 2021-06-04
-
Publication No.: US11462304B2Publication Date: 2022-10-04
- Inventor: Francis Lee , Jonathan D. Steckbeck , Hannes Holste
- Applicant: Peptilogics, Inc.
- Applicant Address: US PA Pittsburgh
- Assignee: Peptilogics, Inc.
- Current Assignee: Peptilogics, Inc.
- Current Assignee Address: US PA Pittsburgh
- Agency: Dickinson Wright, PLLC
- Agent Stephen A. Mason; Jonathan H. Harder
- Main IPC: G16C20/70
- IPC: G16C20/70 ; G06N20/00 ; G16C60/00 ; G16C20/50 ; G06N3/04 ; G06N3/08

Abstract:
An artificial intelligence engine architecture for generating candidate drugs is disclosed. In one embodiment, a method includes generating, via a creator module, a candidate drug compound including a sequence of a candidate drug compound, including the candidate drug compound as a node in a knowledge graph; generating, via a descriptor module, a description of the candidate drug compound at the node in the knowledge graph, wherein the description comprises drug compound structural information, drug compound activity information, and drug compound semantic information; based on the description, performing, via a scientist module, a benchmark analysis of a parameter of the creator module; and modifying, based on the benchmark analysis, the creator module to change the parameter in a desired way during a subsequent benchmark analysis.
Public/Granted literature
- US20210295955A1 ARTIFICIAL INTELLIGENCE ENGINE ARCHITECTURE FOR GENERATING CANDIDATE DRUGS Public/Granted day:2021-09-23
Information query